Search Results - "Aradhye, S"

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results by Comi, G., O'Connor, P., Montalban, X., Antel, J., Radue, E-W., Karlsson, G., Pohlmann, H., Aradhye, S., Kappos, L.

“…In a 6-month, placebo-controlled trial, oral fingolimod (FTY720) 1.25 or 5.0 mg, once daily, significantly reduced MRI inflammatory activity and annualized…”
Get full text

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1‐Year, Randomized Controlled Trial in Europe and Australasia by Salvadori, M., Budde, K., Charpentier, B., Klempnauer, J., Nashan, B., Pallardo, L. M., Eris, J., Schena, F. P., Eisenberger, U., Rostaing, L., Hmissi, A., Aradhye, S.

“…FTY720 is a novel immunomodulator investigated in de novo renal transplantation and other therapeutic areas including multiple sclerosis. This 1‐year…”
Get full text

Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are Comparable by Shaw, Leslie M., Korecka, Magdalena, Aradhye, Shreeram, Grossman, Robert, Bayer, Linda, Innes, Christine, Cucciara, Andrew, Barker, Clyde, Naji, Ali, Nicholls, Andrew, Brayman, Kenneth

“…The possibility of an effect of ethnicity on the pharmacokinetics of mycophenolic acid, the immunosuppressive metabolite of the prodrug mycophenolate mofetil,…”
Get full text

Proof of concept studies for tissue-protective agents in multiple sclerosis by Mehta, LR, Schwid, SR, Arnold, DL, Cutter, GR, Aradhye, S, Balcer, LJ, Calabresi, PA, Cohen, JA, Cole, PE, Glanzman, R, Goelz, S, Inglese, M, Kapoor, R, Kappos, L, Kreitman, R, Lublin, FD, Mann, A, Marrie, RA, O'Looney, P, Polman, CH, Ravina, BM, Reingold, SC, Richert, JR, Sandrock, AW, Waubant, E

“…Background There is considerable interest in tissue-protective treatments for multiple sclerosis (MS). Methods and Objectives We convened a group of MS…”
Get full text

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis by Cohen, Jeffrey A, Barkhof, Frederik, Comi, Giancarlo, Hartung, Hans-Peter, Khatri, Bhupendra O, Montalban, Xavier, Pelletier, Jean, Capra, Ruggero, Gallo, Paolo, Izquierdo, Guillermo, Tiel-Wilck, Klaus, de Vera, Ana, Jin, James, Stites, Tracy, Wu, Stacy, Aradhye, Shreeram, Kappos, Ludwig

“…In this 12-month trial involving patients with relapsing–remitting multiple sclerosis, oral fingolimod was more effective than intramuscular interferon beta-1a…”
Get full text

Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are Comparable by Nicholls, A., Shaw, L.M., Brayman, K., Korecka, M., Aradhye, S., Grossman, R., Bayer, L., Innes, C., Cucciara, A., Barker, C., Naji, A.

Get full text

Utilization of cadaveric kidneys from donors with reactive hepatitis C virus antibody or reactive hepatitis B core antibody by Abrams, J., Nathan, H.M., Brayman, K., Aradhye, S.

Get full text

Scientific principles for mycophenolic acid therapeutic drug monitoring by Shaw, L.M, Korecka, M, Aradhye, S, Grossman, R, Barker, C, Naji, A, Brayman, K.L

Get full text

Decreased rejection episodes in african-american renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy by Weber, M., Deng, S., Arenas, J., Aradhye, S., Grossman, R., Shaw, L., Naji, A., Barker, C., Brayman, K.L.

Get full text

OKT3 induction therapy: influence of duration on rejections and infections by Zibari, G B, Boykin, K N, Thomas, J P, Aultman, D F, Aradhye, S A, McMillan, R W, McDonald, J C

“…Anti-lymphocytes induction therapy in renal transplants remains controversial relative to efficacy and cost benefit. It has been suggested that shortening the…”
Get more information

Single center analysis of mycophenolate mofetil and neoral/prednisone therapy for prophylaxis of rejection in African-American and caucasian transplant recipients by Weber, M., Ketchum, R.J., Sellers, M., Aradhye, S., Deng, S., Grossman, R., Shaw, L., Naji, A., Barker, C., Brayman, K.L.

Get full text

Prevalence of cardiac abnormalities early in the course of systemic lupus erythematosus by Bahl, Vinay K., Vasan, Ramachandran S., Aradhye, S., Malaviya, Anand N.

“…Cardiac lesions involving the endocardium, myocardium, pericardium and coronary vessels are well described in patients with systemic lupus erythematosus (SLE)…”
Get full text

Systemic lupus erythematosus in northern India: a review of 329 cases by Malaviya, A N, Singh, R R, Kumar, A, De, A, Aradhye, S

Get more information

Myocardial systolic function in systemic lupus erythematosus: a study based on radionuclide ventriculography by Bahl, V K, Aradhye, S, Vasan, R S, Malhotra, A, Reddy, K S, Malaviya, A N

“…We assessed left ventricular systolic function by means of radionuclide ventriculography in 20 consecutive unselected patients with systemic lupus…”
Get more information

Effect of anti-lymphocyte induction therapy on renal allograft survival : A meta-analysis by SZCZECH, L. A, BERLIN, J. A, ARADHYE, S, GROSSMAN, R. A, FELDMAN, H. I

“…Induction immunosuppression with antilymphocyte antibodies has not been shown to improve cadaveric kidney allograft survival in randomized, controlled trials…”
Get full text

Clinical management of early progressive renal failure by Aradhye, S

“…In the era of managed health care, the primary physician will be required to play an active role in the management of patients with early renal failure. This…”
Get full text

Identification of α3, α4, and α5 chains of type IV collagen as alloantigens for alport posttransplant anti-glomerular basement membrane antibodies by KALLURI, R, TORRE, A, ARADHYE, S, NEILSON, E. G, SHIELD, C. F, ZAMBORSKY, E. D, WERNER, M. C, SUCHIN, E, WOLF, G, HELMCHEN, U. M, VAN DEN HEUVEL, L. P. W. J, GROSSMAN, R

Get full text

Identification of alpha 3, alpha 4, and alpha 5 chains of type IV collagen as alloantigens for alport posttransplant anti-glomerular basement membrane antibodies by Kalluri, R, Torre, A, Shield, CF III, Zamborsky, ED, Werner, M C, Suchin, E, Wolf, G, Helmchen, U M, van den Heuvel, LPWJ, Grossman, R, Aradhye, S, Neilson, E G

“…Alport syndrome is a hereditary disorder of basement membranes especially affecting the kidneys, ears, and eyes. Some patients who undergo renal…”
Get full text

Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies by Kalluri, R, Torre, A, Shield, 3rd, C F, Zamborsky, E D, Werner, M C, Suchin, E, Wolf, G, Helmchen, U M, van den Heuvel, L P, Grossman, R, Aradhye, S, Neilson, E G

“…Alport syndrome is a hereditary disorder of basement membranes especially affecting the kidneys, ears, and eyes. Some patients who undergo renal…”
Get full text

Will tolerance become a clinical reality? by Aradhye, S, Turka, L A

“…The goal of transplant physicians is to create a state of antigen-specific tolerance in the recipient, whereby the graft is not rejected and the patient will…”
Get more information